EBV+ DLBCL also showed a significantly lower expression of CIITA, MHC II, and B-cell receptor (BCR), but an overexpression of PD-L1, compared with EBV-negative DLBCL. The gene discussed is CIITA; the disease is diffuse large B-cell lymphoma.